Literature DB >> 26869589

The validity of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis.

Arietta Spinou1, Konstantinos C Fragkos2, Kai K Lee3, Caroline Elston3, Richard J Siegert4, Michael R Loebinger5, Robert Wilson5, Rachel Garrod6, Surinder S Birring1.   

Abstract

BACKGROUND: A range of questionnaires have been used to assess health-related quality of life (HRQOL) in bronchiectasis. A systematic review was conducted to evaluate their psychometric properties and assess associations between HRQOL and clinical measures.
METHODS: Five electronic databases were searched. Studies eligible for inclusion were those that investigated the validity of HRQOL questionnaires and/or their association with other outcomes in adults with bronchiectasis. Patients with cystic fibrosis were excluded. The identified questionnaires were assessed for convergent, discriminant and cross-cultural translation validity; missing data, floor and ceiling effects, internal consistency, responsiveness and test-retest reliability. A meta-analysis was conducted to estimate the strength of associations between HRQOL and clinical measures.
RESULTS: From 1918 studies identified, 43 studies were included in the systematic review, of which 38 were suitable for the meta-analysis. Nine HRQOL questionnaires were identified, with the most widely used being: St George's Respiratory Questionnaire, Leicester Cough Questionnaire, Quality of Life-Bronchiectasis and Short Form-36. HRQOL questionnaires had moderate to good internal consistency and good test-retest reliability. Only 8 of 18 studies that used translated HRQOL questionnaires reported or referred to the validity of the translated questionnaire. There was a stronger correlation (mean r (95% CI)) between HRQOL and subjective outcome measures, such as dyspnoea (0.55 (0.41 to 0.68)) and fatigue (0.42 (0.23 to 0.58)) compared with objective measures; exercise capacity (-0.41 (-0.54 to -0.24)), FEV1% predicted (-0.31 (-0.40 to -0.23)) and extent of bronchiectasis on CT scan (0.35 (0.03 to 0.61)); all p<0.001.
CONCLUSIONS: This review supports most HRQOL questionnaires used in bronchiectasis have good psychometric properties. There was a weak to moderate association between HRQOL and objective outcome measures. This suggests that HRQOL questionnaires assess a unique aspect of health not captured by objective measures. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Bronchiectasis

Mesh:

Year:  2016        PMID: 26869589     DOI: 10.1136/thoraxjnl-2015-207315

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  The Objective Assessment of Cough Frequency in Bronchiectasis.

Authors:  Arietta Spinou; Kai K Lee; Aish Sinha; Caroline Elston; Michael R Loebinger; Robert Wilson; Kian Fan Chung; Nadia Yousaf; Ian D Pavord; Sergio Matos; Rachel Garrod; Surinder S Birring
Journal:  Lung       Date:  2017-07-13       Impact factor: 2.584

Review 2.  Review: Quality of Life in Children with Non-cystic Fibrosis Bronchiectasis.

Authors:  Anna Marie Nathan; Jessie Anne de Bruyne; Kah Peng Eg; Surendran Thavagnanam
Journal:  Front Pediatr       Date:  2017-04-24       Impact factor: 3.418

3.  Vitamin D3 supplementation in adults with bronchiectasis: A pilot study.

Authors:  Jim Bartley; Jeff Garrett; Carlos A Camargo; Robert Scragg; Alain Vandal; Rose Sisk; David Milne; Ray Tai; Gene Jeon; Ray Cursons; Conroy Wong
Journal:  Chron Respir Dis       Date:  2018-02-28       Impact factor: 2.444

4.  A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial.

Authors:  Judy Martina Bradley; Rohan Anand; Brenda O'Neill; Kathryn Ferguson; Mike Clarke; Mary Carroll; James Chalmers; Anthony De Soyza; Jamie Duckers; Adam T Hill; Michael R Loebinger; Fiona Copeland; Evie Gardner; Christina Campbell; Ashley Agus; Alistair McGuire; Roisin Boyle; Fionnuala McKinney; Naomi Dickson; Danny F McAuley; Stuart Elborn
Journal:  Trials       Date:  2019-12-19       Impact factor: 2.279

5.  Functional impairment in bronchiectasis: Spirometry parameters versus St. George's Respiratory Questionnaire scores: Any co-relation?

Authors:  Priyanka Singh; C D S Katoch; Vasu Vardhan; Manu Chopra; Sarvinder Singh; Nitin Ahuja
Journal:  Lung India       Date:  2021 Nov-Dec

6.  Efficacy of N-acetylcysteine on idiopathic or postinfective non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis protocol.

Authors:  Ai Luo; Xuemei Liu; Qiongqiong Hu; Mei Yang; Hongli Jiang; Wei Liu
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 2.692

7.  Bronchiectasis Information and Education: a randomised, controlled feasibility trial.

Authors:  Katy L M Hester; Vicky Ryan; Julia Newton; Tim Rapley; Anthony De Soyza
Journal:  Trials       Date:  2020-04-15       Impact factor: 2.279

8.  Psychometric Validation of the German Translation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B)-Data from the German Bronchiectasis Registry PROGNOSIS.

Authors:  Laura Quellhorst; Grit Barten-Neiner; Andrés de Roux; Roland Diel; Pontus Mertsch; Isabell Pink; Jessica Rademacher; Sivagurunathan Sutharsan; Tobias Welte; Annegret Zurawski; Felix C Ringshausen
Journal:  J Clin Med       Date:  2022-01-15       Impact factor: 4.241

9.  Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis.

Authors:  Rebecca H McLeese; Arietta Spinou; Zina Alfahl; Michail Tsagris; J Stuart Elborn; James D Chalmers; Anthony De Soyza; Michael R Loebinger; Surinder S Birring; Konstantinos C Fragkos; Robert Wilson; Katherine O'Neill; Judy M Bradley
Journal:  Eur Respir J       Date:  2021-11-11       Impact factor: 16.671

10.  Prevalence of depression and its associated factors in bronchiectasis: findings from KMBARC registry.

Authors:  Ji-Ho Lee; Won-Yeon Lee; Suk Joong Yong; Woo Jin Kim; Sooim Sin; Chang Youl Lee; Youlim Kim; Ji Ye Jung; Sang-Ha Kim
Journal:  BMC Pulm Med       Date:  2021-09-27       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.